These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6099675)

  • 1. [Studies on long-term intermittent immunochemotherapy of lung cancer--with special reference to surgical cases].
    Fukami A
    Igaku Kenkyu; 1984 Apr; 54(4):383-400. PubMed ID: 6099675
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy].
    Watanabe Y; Sato H; Iida S; Yamada T; Kobayashi H; Kimoto H; Tsunamura Y; Ichihashi T; Shimizu J; Hashizume Y
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):21-35. PubMed ID: 2981515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of postoperative immunochemotherapy in lung cancer].
    Ikeda T; Sakai T; Suito T; Kosaki G
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1044-9. PubMed ID: 3008669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of immunotherapy with the streptococcal preparation OK-432 in non-small cell lung cancer.
    Watanabe Y; Iwa T
    J Biol Response Mod; 1987 Apr; 6(2):169-80. PubMed ID: 3585412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relation between prognosis and the Su-PS skin reaction in patients with non-resected primary lung cancer receiving OK-432].
    Nakarai I; Rikitake H; Koga T; Hayashi A; Harada Y; Takamoto M; Ishibashi T; Shinoda A; Sagawa K
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3050-7. PubMed ID: 2823723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer.
    Hansen HH; Rørth M
    Cancer Chemother Biol Response Modif; 1991; 12():443-59. PubMed ID: 1657089
    [No Abstract]   [Full Text] [Related]  

  • 7. [An analysis of the therapeutic effects of 120 cases of lung cancer in the elderly].
    Xu YN
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1985 Dec; 8(6):321-4, 372. PubMed ID: 3015519
    [No Abstract]   [Full Text] [Related]  

  • 8. [Significance of immunotherapy as an adjunct to surgical treatment in non-small cell carcinoma of the lung].
    Fujisawa T
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):13-20. PubMed ID: 2981513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of monitoring serum carcinoembryonic antigen (CEA) levels for prognosis of patients with lung cancer treated by non-surgical methods].
    Ochnio J; Rogińska E; Kwiek S; Rowińska-Zakrzewska E
    Pneumonol Pol; 1984 Jul; 52(7):321-9. PubMed ID: 6093066
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of concomitant use of immunomodulator (OK-432 and/or PSK) on advanced lung cancer (squamous cell carcinoma and adenocarcinoma) treated with radiation with combined chemotherapy].
    Ogawa Y; Kimura S; Imajo Y; Hiratsuka J; Ichiyanagi A; Ashida C; Oshitani T; Imanaka K; Obayashi K; Takada Y
    Rinsho Hoshasen; 1982 Dec; 27(13):1445-8. PubMed ID: 7166858
    [No Abstract]   [Full Text] [Related]  

  • 11. [What is safe in the therapy of non-small cell bronchial cancer?].
    Gropp C
    Internist (Berl); 1984 Dec; 25(12):747-51. PubMed ID: 6097563
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of postoperative immunochemotherapy of lung cancer].
    Ikeda T; Sakai T; Suito T; Kosaki G
    Nihon Kyobu Geka Gakkai Zasshi; 1987 Jan; 35(1):1-4. PubMed ID: 3572111
    [No Abstract]   [Full Text] [Related]  

  • 13. Meta-analysis of adjuvant immunochemotherapy using OK-432 in patients with resected non-small-cell lung cancer.
    Sakamoto J; Teramukai S; Watanabe Y; Hayata Y; Okayasu T; Nakazato H; Ohashi Y;
    J Immunother; 2001; 24(3):250-6. PubMed ID: 11394503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy and immunotherapy of pulmonary cancer].
    Cardinali G
    Minerva Med; 1979 Jan; 70(3):273-82. PubMed ID: 219398
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of chorionic gonadotropin during the dynamic observation of patients with lung cancer].
    Struzhko IB; Lebedev AS; Zueva OM
    Vopr Onkol; 1991; 37(7-8):878. PubMed ID: 1668806
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prognostic factors in lung cancer based on Shanghai population].
    Liao ML; Gao YT; Yang ZP
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(1):36-8, 63-4. PubMed ID: 8403060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thai experience in lung cancer treatment.
    Limsila T
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):646-50. PubMed ID: 3012791
    [No Abstract]   [Full Text] [Related]  

  • 18. Lung cancer.
    Hansen HH; Rørth M
    Cancer Chemother Biol Response Modif; 1987; 9():239-56. PubMed ID: 2856335
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of endoscopical administration of OK-432 in 4 patients with advanced esophageal or gastric cancer].
    Satomi T; Inoue S; Fujita T; Ogawa S; Honda H; Hayashi M
    Gan No Rinsho; 1989 Mar; 35(4):512-5. PubMed ID: 2541269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunochemotherapy of resectable lung cancer--a preliminary study on a comparison of the control, levamisole, and OK-432].
    Okayasu T; Kashimura Y; Matano J; Kawabata M; Takeoka T; Hashimoto M; Tanabe T
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1646-52. PubMed ID: 6764120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.